PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology, Department of Medicine, University of Perugia, Piazzale Giorgio Menghini, 1, 06129, Perugia, Italy.\', \'Rheumatology and Clinical Immunology Humanitas Research Hospital, Rozzano, Milan, Italy.\', \'Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Aviv University, 5265601, Tel-Hashomer, Israel.\', \'The Mosaic of Autoimmunity Project, Saint Petersburg University, Saint Petersburg, Russia.\', \'Ministry of Health of the Russian Federation, Sechenov First Moscow State Medical University, Moscow, Russia.\', \'Rheumatology, Department of Medicine, University of Perugia, Piazzale Giorgio Menghini, 1, 06129, Perugia, Italy. roberto.gerli@unipg.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12026-020-09145-5
?:doi
?:hasPublicationType
?:journal
  • Immunologic research
is ?:pmid of
?:pmid
?:pmid
  • 32681497
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.198
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all